留尼汪与马约特岛人及伴侣动物中产IMI-4碳青霉烯酶肠杆菌的特征
研究对西南印度洋地区(留尼汪与马约特岛)患者和一只伴侣动物分离的产blaIMI-4碳青霉烯酶肠杆菌复合群菌株进行药敏试验和基因组测序。结果显示blaIMI-4菌株对头孢他啶-阿维巴坦、美罗培南-伐博巴坦等新型β-内酰胺酶抑制剂复方敏感,blaIMI-4基因位于EcloIMEX-2可移动整合元件上,该元件在犬源ST2370 Enterobacter sichuanensis及人源ST1845 Enterobacter roggenkampii临床分离株中均有发现。伴侣动物可能参与碳青霉烯耐药可移动遗传元件的持续与传播。
要点
- 产blaIMI-4肠杆菌复合群菌株对头孢他啶-阿维巴坦和美罗培南-伐博巴坦敏感。
- blaIMI-4基因位于EcloIMEX-2可移动整合元件,在犬源和人源菌株中均检出。
- 伴侣动物可能参与碳青霉烯耐药可移动遗传元件的持续与传播。
核心结论
- 伴侣动物可能在赋予多种肠杆菌碳青霉烯耐药的可移动遗传元件的持续和传播中发挥作用。
研究设计与样本
- 对留尼汪和马约特岛患者及一只伴侣动物分离的产blaIMI-4碳青霉烯酶肠杆菌复合群菌株进行抗生素敏感性试验和基因组测序。
主要发现
- blaIMI-4肠杆菌复合群分离株对作用于A类碳青霉烯酶的新型抗生素敏感,特别是β-内酰胺酶抑制剂复方(头孢他啶-阿维巴坦、美罗培南-伐博巴坦)。
- blaIMI-4基因位于共同的EcloIMEX-2可移动整合元件上,该元件见于留尼汪一只犬分离的ST2370 Enterobacter sichuanensis以及留尼汪和马约特岛分离的ST1845 Enterobacter roggenkampii临床分离株。
临床怎么用
- 对产blaIMI-4肠杆菌复合群感染,可考虑使用头孢他啶-阿维巴坦或美罗培南-伐博巴坦等新型β-内酰胺酶抑制剂复方。
- 在碳青霉烯耐药肠杆菌复合群监测中,应关注伴侣动物作为可移动遗传元件潜在储库的可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Carbapenemase-producing Enterobacterales (CPE) are a significant public health concern, associated with high morbidity and mortality rates due to restricted antibiotic treatment options. Among the genetic determinants of CPE resistance, imipenemase (IMI) mediated resistance is an emerging problem in infections involving bacteria of the Enterobacter cloacae complex (ECC) and has been linked to worldwide clinical cases, including community-level outbreaks in the Indian Ocean region. Little is known about the potential role of animals as reservoirs of multidrug-resistant ECC bacteria. OBJECTIVES: Characterize blaIMI-4 carbapenemase-producing ECC strains isolated from patients and a companion animal in the southwestern Indian Ocean region (Réunion and Mayotte islands). METHODS: We used antibiotic susceptibility testing to determine available treatment and genome sequencing to characterize resistance gene variants and mobile genetic elements carrying blaIMI-4 genes. RESULTS: blaIMI-4 ECC isolates are susceptible to new antibiotics active on Class A carbapenemase, notably β-lactams-inhibitors (ceftazidime-avibactam, meropenem-vaborbactam). The blaIMI-4 gene was identified on a common EcloIMEX-2 mobile integrative element in (i) ST 2370 Enterobacter sichuanensis isolated from a dog in Réunion and (ii) ST1845 Enterobacter roggenkampii clinical isolates from Réunion and Mayotte islands. CONCLUSIONS: Companion animals may play a role in the persistence and spread of mobile genetic elements that confer carbapenem resistance in diverse Enterobacter species.
引用
- Wilkinson DA, Sellier A, Maurines-Carboneill C, et al. Characterization of IMI-4 carbapenemase-producing Enterobacter sp. isolated from humans and a companion animal in French Indian Ocean territories. J Antimicrob Chemother. 2026. PMID: 42446385. doi:10.1093/jac/dkag243
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。